Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland, Gregory Kaltsas, Wouter W. de Herder
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 371-403
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Guido Rindi, Özgür Mete, Silvia Uccella, et al.
Endocrine Pathology (2022) Vol. 33, Iss. 1, pp. 115-154
Closed Access | Times Cited: 553
A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management
Qamar Sultana, Jill Kar, Amogh Verma, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5138-5138
Open Access | Times Cited: 44
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art
Felipe Lopez-Ramirez, Mohammad Yasrab, Florent Tixier, et al.
Seminars in Nuclear Medicine (2025)
Closed Access | Times Cited: 2
The Impact of SARS-Cov-2 Virus Infection on the Endocrine System
Noel Somasundaram, Ishara Ranathunga, Vithiya Ratnasamy, et al.
Journal of the Endocrine Society (2020) Vol. 4, Iss. 8
Open Access | Times Cited: 78
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy
Richard P. Baum, Jingjing Zhang, Christiane Schuchardt, et al.
Journal of Nuclear Medicine (2021) Vol. 62, Iss. 11, pp. 1571-1581
Open Access | Times Cited: 70
The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5
Oana Popa, Sorina Tãban, Stelian Pantea, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 57
Approach to the Patient: Insulinoma
Johannes Hofland, Julie Refardt, Richard A. Feelders, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 4, pp. 1109-1118
Open Access | Times Cited: 25
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Maria J. Klomp, Simone U. Dalm, Marion de Jong, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 495-510
Open Access | Times Cited: 53
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
Philip E. Harris, Konstantin Zhernosekov
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 38
The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors—An Overview of the Latest Classifications
Ancuța-Augustina Gheorghișan-Gălățeanu, Andreea Ilieșiu, Ioana Maria Lambrescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1418-1418
Open Access | Times Cited: 21
Evolution of Liver Transplantation Indications: Expanding Horizons
Sara Battistella, Marco Grasso, Elisa Catanzaro, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 412-412
Open Access | Times Cited: 8
Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
Julie Refardt, Johannes Hofland, Kwadwo Antwi, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 581-594
Closed Access | Times Cited: 41
Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
Wouter T. Zandee, Tessa Brabander, Anela Blažević, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 9, pp. e3665-e3672
Open Access | Times Cited: 41
Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot
Cornelius James Fernandez, Mayuri Agarwal, Biju Pottakkat, et al.
World Journal of Gastrointestinal Surgery (2021) Vol. 13, Iss. 3, pp. 231-255
Open Access | Times Cited: 33
Peptide Receptor Radionuclide Therapy
Johannes Hofland, Tessa Brabander, Frederik A. Verburg, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 12, pp. 3199-3208
Open Access | Times Cited: 26
Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
Apostolos Koffas, Alexandros Giakoustidis, Apostolis Papaefthymiou, et al.
Frontiers in Surgery (2023) Vol. 10
Open Access | Times Cited: 15
Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis
Jianmei Pan, Zhang Xiao-hua, Yongjun Shi, et al.
Scandinavian Journal of Gastroenterology (2018) Vol. 53, Iss. 9, pp. 1139-1145
Closed Access | Times Cited: 44
Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
Virginia Liberini, Bruno De Santi, Osvaldo Rampado, et al.
EJNMMI Physics (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 28
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors
Andrew Poklepovic, Sarah Gordon, Sejal Kothadia, et al.
Anti-Cancer Drugs (2024)
Open Access | Times Cited: 4
Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)
Jianming Xu
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 25
Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
Aadil Adnan, Sandip Basu
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2154-2154
Open Access | Times Cited: 11
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators
Merijn C F Mulders, Wouter W. de Herder, Johannes Hofland
Endocrine Reviews (2023) Vol. 45, Iss. 3, pp. 351-360
Open Access | Times Cited: 11
The radiologic spectrum of neuroendocrine tumors in emergent care
Asutosh Sahu, Michael N. Patlas, Ankush Jajodia
Reviews in Endocrine and Metabolic Disorders (2025)
Closed Access
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes
Sara Massironi, Lorenzo Gervaso, Fabrizio Fanizzi, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 212-212
Open Access
miR-223 and Chromogranin A Affect Inflammatory Immune Cell Activation in Liver Metastasis of Neuroendocrine Neoplasms
Lukas Geisler, Katharina Detjen, Teresa Hellberg, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 111-111
Open Access
Page 1 - Next Page

Scroll to top